Market research
NXG.V NexgenRx Inc
V CAD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 47M
- P/E ratio
- 33.0
- Analyst target
- 4.25
- Dividend yield
- 0.0%
- Beta
- 0.52
Community
Investor discussion
1 comment
Sign in to join the NXG.V discussion.
5 years, 5 months ago
NexgenRx Inc is currently in a long term uptrend where the price is trading 23.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.3.
NexgenRx Inc's total revenue rose by 3.6% to $3M since the same quarter in the previous year.
Its net income has increased by 918.9% to $510K since the same quarter in the previous year.
Finally, its free cash flow grew by 329.6% to $909K since the same quarter in the previous year.
Based on the above factors, NexgenRx Inc gets an overall score of 5/5.